Investment analysts at Citigroup began coverage on shares of Omega Healthcare Investors (NYSE:OHI) in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The brokerage set a “neutral” rating and a $44.00 price target on the real estate investment trust’s stock. Citigroup‘s target price suggests a potential upside of 1.78% from the company’s current price.
Several other analysts also recently commented on the stock. Zacks Investment Research downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Wednesday, January 8th. Raymond James downgraded shares of Omega Healthcare Investors from a “strong-buy” rating to a “market perform” rating in a report on Monday, October 21st. Wells Fargo & Co reiterated a “hold” rating on shares of Omega Healthcare Investors in a report on Monday, December 9th. Mizuho began coverage on shares of Omega Healthcare Investors in a report on Thursday, December 19th. They set a “buy” rating and a $50.00 price objective for the company. Finally, Bank of America restated a “buy” rating and set a $44.50 price objective on shares of Omega Healthcare Investors in a report on Monday, October 14th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. Omega Healthcare Investors presently has a consensus rating of “Hold” and a consensus price target of $43.32.
Shares of OHI stock opened at $43.23 on Wednesday. The firm has a 50-day moving average of $42.19 and a 200-day moving average of $40.96. The company has a market cap of $9.62 billion, a P/E ratio of 26.69, a P/E/G ratio of 5.53 and a beta of 0.31. The company has a debt-to-equity ratio of 1.13, a current ratio of 3.00 and a quick ratio of 3.00. Omega Healthcare Investors has a one year low of $34.64 and a one year high of $45.01.
In related news, insider Steven J. Insoft sold 50,000 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $44.00, for a total transaction of $2,200,000.00. Following the completion of the sale, the insider now owns 183,032 shares in the company, valued at $8,053,408. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.16% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of OHI. Huntington National Bank purchased a new stake in Omega Healthcare Investors during the fourth quarter worth about $27,000. Phocas Financial Corp. bought a new position in Omega Healthcare Investors during the second quarter worth about $32,000. FTB Advisors Inc. boosted its position in Omega Healthcare Investors by 48.4% during the fourth quarter. FTB Advisors Inc. now owns 766 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 250 shares during the period. Arlington Partners LLC bought a new position in Omega Healthcare Investors during the fourth quarter worth about $38,000. Finally, Stonebridge Capital Advisors LLC bought a new position in Omega Healthcare Investors during the second quarter worth about $40,000. Institutional investors and hedge funds own 75.28% of the company’s stock.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Recommended Story: Understanding Analyst Recommendations
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.